Incidences of diseases caused by vitamin D deficiency such as rickets have been increasing in some developing and also underdeveloped countries around the world. Rickets is a skeletal disorder caused by lack of vitamin D, calcium, or phosphate. Increasing cases of child malnourishment, which is a condition that results from consuming foods that lack sufficient nutrients and causes health problems. Increasing incidence of osteoporosis and osteomalacia in various countries across the globe is a major factor driving demand for vitamin D and related products.
Do Inquiry About Report Here: https://marketresearch.biz/report/vitamin-d-market/#inquiry
However, regulatory standards in some countries to prevent vitamin D toxicity is a factor restraining growth of the market.
North America dominated the global market, accounting for around XX% of the total market revenue in 2016. Development in emerging markets such as Brazil, Italy, India, and China is paving way for new and lucrative opportunities for growth of this market.
Key players in the global biosimilars market include Abbott Laboratories, Archer Daniels Midland Company, BASF SE, Fermenta Biotech Ltd., Groupe Danone SA, Koninklijke Dsm NV, Kraft Foods Group, Inc., Nestle SA, Pfizer, Inc., and Synthesia, AS.